ISSCR News
The ISSCR is Updating its Guidelines
Stem cell science, its clinical application, and the ethical issues surrounding it have rapidly advanced since the release of the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation…
ISSCR Comments on Brazil’s Advanced Therapy Medicinal Products Regulation
The ISSCR submitted comments to Brazil’s health regulatory agency (ANVISA) regarding the proposed regulations for advanced therapy medicinal products (Public Consultation No. 706).
Lawrence Goldstein Policy Fellows Announced
The ISSCR is pleased to announce the recipients of the inaugural Lawrence Goldstein Policy Fellowship, Mohamed Abou El-Enein, PhD (Charité Universitätsmedizin, Berlin, Germany) and Zubin Master, PhD (Mayo Clinic, Rochester, MN, U.S.).
ISSCR Policy Advocacy in Action
Polices created by legislators and regulators can have a profound impact on stem cell and biomedical research and the development of new treatments. While individual researchers may feel vulnerable to new policies and powerless to change them alone, the ISSCR represents a collective and influential voice of over 4,000 stem cell scientists, clinicians, and professionals that is having an impact.
ISSCR Applauds Google’s New Policy Banning Ads on Unproven Therapies
6 September 2019 -- The International Society for Stem Cell Research (ISSCR) today released the following statement regarding Google’s new policy that bans advertisements from unproven stem cell clinics and other speculative medical interventions.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .